Long-term study of KT-621 for asthma patients from previous study
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial is for people with asthma who already completed a previous study of the drug KT-621. It aims to see if taking KT-621 for a longer time is safe and helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have finished all visits of the earlier KT-621 asthma study, including the final treatment visit.
- You must be willing and able to follow the study schedule, have lab tests, fill out questionnaires, and use an electronic diary.
- You must agree to use birth control as required by the study and local rules.
- You must not have had any major health changes in the earlier study that would make this study unsafe for you.
- You must not have had a side effect in the earlier study that makes continued treatment risky.
- You must not have stopped the earlier study treatment early or been permanently removed from it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
This trial tests an oral medication called KT-621 for people with moderate to severe eosinophilic asthma. It aims to see if the drug can help control asthma better than the standard inhaled treatments alone.
This trial is testing an investigational drug called CDX-622 for people with mild to moderate asthma. The study aims to see if it can help control asthma symptoms and improve lung function.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
This trial compares two different forms of an investigational drug to see how they are absorbed into the body. It is for healthy volunteers who want to help researchers understand the safest and most effective way to give the drug.
Hear when a new Asthma (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.